Stay updated with breaking news from Invo Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Josh Beckerman Shares of INVO BioScience, which is merging with NAYA Biosciences, rose 5% Tuesday after NAYA entered a binding term sheet to buy gene...
INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) was the target of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 196,700 shares, a decline of 80.3% from the November 15th total of 997,200 shares. Based on an average daily volume of 3,830,000 shares, […]
INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) was the target of a significant increase in short interest in October. As of October 31st, there was short interest totalling 289,000 shares, an increase of 397.4% from the October 15th total of 58,100 shares. Based on an average daily volume of 1,840,000 shares, the short-interest ratio […]
/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services company focused on expanding access to advanced fertility...
Shares of INVO Bioscience, Inc. (INVO) surged on a deal to buy NAYA Biosciences in an all-stock deal. INVO is currently trading at $2.8400, up $2.3000 or 425.